Investigating the genetics of Hodgkin lymphoma that doesn't respond to treatment
Deep Sequencing of Relapse and Refractory Hodgkin Lymphoma Genomes: A Study of Tumor Biology and Evolution
This study is looking at the genetic changes in Hodgkin lymphoma to find out why some patients don’t respond to standard treatments or have relapses, with the hope of discovering better treatment options for those who need them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10908251 on NIH RePORTER |
What this research studies
This research focuses on understanding the genetic changes in Hodgkin lymphoma, particularly in cases where the disease does not respond to standard treatments or relapses. By using advanced genome sequencing techniques, the study aims to identify specific genetic variants that contribute to treatment resistance. Patients with relapsed or refractory Hodgkin lymphoma will be analyzed to uncover the underlying tumor biology and evolution, which could lead to the development of more effective targeted therapies. The research seeks to improve risk assessment and treatment options for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with relapsed or refractory Hodgkin lymphoma who have not responded to standard treatment.
Not a fit: Patients with newly diagnosed Hodgkin lymphoma who are responding well to standard treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new targeted therapies and improved survival rates for patients with relapsed or refractory Hodgkin lymphoma.
How similar studies have performed: Previous research has shown promise in using advanced sequencing technologies to understand cancer genetics, suggesting potential for success in this novel approach.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Gomez, Felicia — Washington University
- Study coordinator: Gomez, Felicia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.